Page last updated: 2024-10-26

dimaprit and Prostatic Neoplasms

dimaprit has been researched along with Prostatic Neoplasms in 1 studies

Dimaprit: A histamine H2 receptor agonist that is often used to study the activity of histamine and its receptors.

Prostatic Neoplasms: Tumors or cancer of the PROSTATE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zhao, J1
Wang, J1
Liu, Y1
Han, XX1
Xu, B1
Ozaki, Y1
Zhao, B1

Other Studies

1 other study available for dimaprit and Prostatic Neoplasms

ArticleYear
Detection of prostate cancer biomarkers via a SERS-based aptasensor.
    Biosensors & bioelectronics, 2022, Nov-15, Volume: 216

    Topics: Aptamers, Nucleotide; Biomarkers, Tumor; Biosensing Techniques; Dimaprit; DNA, Complementary; Gold;

2022